Drug could be the first and only in Europe to treat rare brain condition
A drug to treat a rare condition characterized by brain dysfunction has been recommended for marketing authorization.
Source: labiotech.eu
Stay updated with breaking news from Neil Kumar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A drug to treat a rare condition characterized by brain dysfunction has been recommended for marketing authorization.
- CHMP recommendation for approval of NULIBRY in the European Union (EU) for the treatment of patients with molybdenum cofactor deficiency (MoCD) Type A is...
GuruFocus Article or News written by GuruFocusNews and the topic is about:
Advocates have long been encouraged to start pushing their political agendas at the local level. In recent years, extremists have heeded that advice.